HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways

References

• Abraham JA, Damm D, Bajardi A, Miller J, Klagsbrun M, Ezekowitz AB. Heparin-binding EGF-like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem Biophys Res Commun 1993; 190: 125–133
   PubMed Web of Science ®Google Scholar
• Abramovitch R, Neeman M, Reich R, Stein I, Keshet E, Abraham J, Solomon A, Marikovsky M. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett 1998; 425: 441–447
   PubMedGoogle Scholar
• Arkonac BM, Foster LC, Sibinga NES, Patterson C, Lai K, Tsai J-C, Lee M-E, Perrella MA, Haber E. Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells. J Biol Chem 1998; 273: 4400–4405
   Google Scholar
• Besner G, Higashiyama S, Klagsbrun M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul 1990; 1: 811–819
   PubMedGoogle Scholar
• Besner G, Whelton D, Crissman-Combs M, Steffen C, Kim G, Brigstock D. Heparin dependence of the interaction of heparin-binding EGF-like growth factor with the EGF receptor. Mol Biol Cell 1992; 3: H22
   Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389–395
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–257
   PubMed Web of Science ®Google Scholar
• Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49: 507–521
   PubMed Web of Science ®Google Scholar
• D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol 1987; 49: 453–464
   PubMed Web of Science ®Google Scholar
• Davis KM, Brigstock DR, Johnson PR, Crissman-ombs MA, McCarthy DW, Downing MT, Besner GE. Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus. Protein Expr Purif 1996; 8: 57–67
   PubMed Web of Science ®Google Scholar
• El-Assal ON, Besner GE. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 2005; 129: 609–625
   PubMed Web of Science ®Google Scholar
• Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 1997; 16: 1268–1278
   PubMedGoogle Scholar
• Eliceiri BP, Klemke R, Stromblad S, Cheresh DA. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 1998; 140: 1255–1263
   PubMed Web of Science ®Google Scholar
• Fang L, Li G, Liu G, Lee SW, Aaronson SA. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J 2001; 20: 1931–1939
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31
   PubMed Web of Science ®Google Scholar
• Fujio Y, Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 1999; 274: 16349–16354
   PubMed Web of Science ®Google Scholar
• Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun C-O, Buerk DG, Huang PL, Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. PNAS 2001; 98: 2604–2609
   PubMed Web of Science ®Google Scholar
• Gerber H-P, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998; 273: 30336–30343
   PubMed Web of Science ®Google Scholar
• Gordon JD, Shifren JL, Foulk RA, Taylor RN, Jaffe RB. Angiogenesis in the human female reproductive tract. Obstet Gynecol Surv 1995; 50: 688–697
   PubMedGoogle Scholar
• Guo D, Jia Q, Song HY, Warren RS, Donner DB. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J Biol Chem 1995; 270: 6729–6733
   PubMed Web of Science ®Google Scholar
• Helmlinger G, Endo M, Ferrara N, Hlatky L, Jain RK. Formation of endothelial cell networks. Nature 2000; 405: 139–141
   PubMed Web of Science ®Google Scholar
• Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251: 936–939
   PubMed Web of Science ®Google Scholar
• Homma T, Sakai M, Cheng HF, Yasuda T, Coffee RJ, Harris RC. Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest 1995; 96: 1018–1025
   PubMed Web of Science ®Google Scholar
• Iwamoto R, Mekada E. Heparin-binding EGF-like growth factor: A juxtacrine growth factor. Cytokine Growth Factor Rev 2000; 11: 335–344
   PubMed Web of Science ®Google Scholar
• Klagsbrun M. Regulators of angiogenesis: Stimulators, inhibitors and extracellular matrix. J Cell Biochem 1991a; 47: 199–200
   Google Scholar
• Klagsbrun M. Angiogenic factors: Regulators of blood supply-side biology. FGF, endothelial cell growth factors and angiogenesis: A keystone symposium, Keystone, CO, USA, April 1–7, 1991. New Biol 1991b; 3: 745–749
   PubMedGoogle Scholar
• Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991; 53: 217–239
   PubMed Web of Science ®Google Scholar
• Lee M, Aoki M, Kondo T, Kobayashi K, Okumura K, Komori K, Murohara T. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Arterioscler Thromb Vasc Biol 2005; 25: 2535–2541
   Google Scholar
• Majumdar APN, Du J. Phosphatidylinositol 3-kinase/Akt signaling stimulates colonic mucosal cell survival during aging. Am J Physiol Gastrointest Liver Physiol 2006; 290: G49–G55
   Google Scholar
• Mehta VB, Besner GE. Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-kappa B activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway. J Immunol 2005; 175: 1911–1918
   PubMed Web of Science ®Google Scholar
• Montesano R, Pepper MS, Belin D, Vassalli JD, Orci L. Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases. J Cell Physiol 1988; 134: 460–466
   PubMed Web of Science ®Google Scholar
• Morita T, Yoshizumi M, Kurihara H, Maemura K, Nagai R, Yazaki Y. Shear stress increases heparin-binding epidermal growth factor-like growth factor mRNA levels in human vascular endothelial cells. Biochem Biophy Res Commun 1993; 197: 256–262
   PubMed Web of Science ®Google Scholar
• Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69: 1051–1061
   PubMed Web of Science ®Google Scholar
• Nishi E, Prat A, Hospital V, Elenius K, Klagsbrun M. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J 2001; 20: 3342–3350
   PubMedGoogle Scholar
• Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131–3139
   PubMed Web of Science ®Google Scholar
• Raab G, Higashiyama S, Hetelekidis S, Abraham JA, Damm D, Ono M, Klagsbrun M. Biosynthesis and processing by phorbol ester of the cell surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem Biophys Res Commun 1994; 204: 592–597
   PubMed Web of Science ®Google Scholar
• Rifkin DB, Tsuboi R, Mignatti P. The role of proteases in matrix breakdown during cellular invasion. Am Rev Respir Dis 1989; 140: 1112–1113
   Google Scholar
• Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671–674
   PubMed Web of Science ®Google Scholar
• Rudic RD, Sessa WC. Nitric oxide in endothelial dysfunction and vascular remodeling: Clinical correlates and experimental links. Am J Hum Genet 1999; 64: 673–677
   PubMed Web of Science ®Google Scholar
• Sato Y, Morimoto A, Kiue A, Okamura K, Hamanaka R, Kohno K, Kuwano M, Sakata T. Irsogladine is a potent inhibitor of angiogenesis. FEBS Lett 1993; 322: 155–158
   Google Scholar
• Sessa WC. eNOS at a glance. J Cell Sci 2004; 117: 2427–2429
   PubMed Web of Science ®Google Scholar
• Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002; 90: 1243–1250
   PubMed Web of Science ®Google Scholar
• Smith RS, Jr., Lin K-F, Agata J, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler Thromb Vasc Biol 2002; 22: 1279–1285
   PubMed Web of Science ®Google Scholar
• Sugiura S, Kitagawa K, Tanaka S, Todo K, Omura-Matsuoka E, Sasaki T, Mabuchi T, Matsushita K, Yagita Y, Hori M. Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke 2005; 36: 859–864
   PubMed Web of Science ®Google Scholar
• Ushiro S, Ono M, Izumi H, Kohno K, Taniguchi N, Higashiyama S, Kuwano M. Heparin-binding epidermal growth factor-like growth factor: p91 activation, induction of plasminogen activator/plasminogen activator inhibitor, and tubular morphogenesis in human microvascular endothelial cells. Jpn J Cancer Res 1996; 87: 68–77
   Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8
   PubMed Web of Science ®Google Scholar